More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...
HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...
Men with HIV and severe sleep-disordered breathing experience the greatest sleep disruption, with lower efficiency, more light sleep, and unstable sleep stages.
1don MSNOpinion
The only thing standing between humanity and the end of HIV
A new drug called lenacapavir might entirely change the game, though.
South Africa’s health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a “groundbreaking” tool ...
The "miracle tool" HIV medicine lenacapavir will be sold in South Africa from as early as March or April 2026 according to ...
The 21-valent pneumococcal conjugate vaccine V116 is well tolerated in adults living with HIV and induces immunity to all 21 ...
allAfrica.com on MSN
South Africa to roll out revolutionary HIV medication in 2026
Lenacapavir is a revolutionary long-acting injectable drug that offers six months of protection with just two annual ...
The adult-specific 21-valent pneumococcal conjugate vaccine was well tolerated and immunogenic across all 21 serotypes in patients with HIV infection.
The Punch on MSN
Institute urges persons living with HIV to adhere to treatment
The Institute of Human Virology Nigeria has urged People Living with HIV to adhere to their prescribed medications to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results